Pharmasund Nordic ApS: Financial statements 2024
CVR: 41686669
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pharmasund Nordic ApS (CVR 41686669) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 63,944 and a net result of DKK 63,921 compared with DKK -77,235 the year before. Equity in the 2024 report amounted to DKK -87,400.
- Gross Profit
- DKK 63,944
- Profit/Loss
- DKK 63,921
- Equity
- DKK -87,400
- Total Assets
- DKK 355,064
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 64K | 64K | -87K | 0 |
| 2023 | - | - | -77K | -151K | 0 |
| 2022 | - | - | 0 | 50K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Pharmasund Nordic ApS has published its annual report for 2023. The net result was DKK -77,235.
As of February 2, 2024, Ismail Nayef Ismail Khdeir is registered as adm. dir. of Pharmasund Nordic ApS.
As of February 2, 2024, Mette Lund Lavesen has stepped down as director of Pharmasund Nordic ApS.
About Pharmasund Nordic ApS
Pharmasund Nordic ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2020. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Ismail Nayef Ismail Khdeir. The company is owned by P8 Ventures ApS, IDAN Invest ApS and Hjerpsted Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 151,397 and a net result of DKK 113,664 compared with DKK 63,921 the year before. Equity in the 2025 report amounted to DKK 26,264.
